Ruminant BioTech Launches CAD$7.6M Research Program in Canada for Methane Reduction Technology
Ruminant BioTech, a New Zealand startup, has initiated a CAD$7.6 million research program in Canada to validate its slow-release livestock methane reduction technology. The three-year program, supported by a CAD$2.8 million grant from the Alberta government and industry partnerships, aims for commercialization in Canada. The company plans to establish its North American base in Calgary and aims to treat 100 million cows globally by 2035.
Theia Market Signal Identification - AI Assisted
Ruminant BioTech has launched a CAD$7.6 million ($5.6 million) research program in Canada to validate its methane reduction technology for cattle. The three-year initiative is supported by a CAD$2.8 million grant from the Alberta government, along with CAD$3.4 million from industry partners.
The company will establish its North American base in Calgary, starting the project in August with local colleges and research facilities. The technology, a slow-release bolus that delivers bromoform, can reportedly reduce methane emissions by 75% for over three months. Initial regulatory approval is anticipated in New Zealand by early 2026, with plans to treat 100 million cows globally by 2035.
Comments